Biological Study for Leishmaniasis Cutaneous In Thi-Qar Governorate
Studi Biologis untuk Leishmaniasis Kutaneus di Kegubernuran Thi-Qar
Keywords:
Cutaneous Leishmaniasis, Dhi-Qar Governorate, Epidemiology, Seasonal Variation, Public HealthAbstract
General Background: Cutaneous leishmaniasis (CL), a parasitic disease transmitted by sandflies, remains a pressing public health issue in endemic regions. Specific Background: In Iraq, particularly within Dhi-Qar Governorate, CL has shown persistent prevalence, yet comprehensive long-term surveillance is limited. Knowledge Gap: Despite various clinical and diagnostic advancements, there is a lack of regional data analyzing demographic, geographic, and seasonal trends in CL incidence over an extended period. Aims: This study aims to monitor and evaluate the epidemiological patterns of CL in Dhi-Qar from 2020 to 2024 using hospital surveillance data. Results: A total of 3,882 cases were recorded, with a higher prevalence among males (53.16%) and rural residents (52.53%). Children aged 5–15 were the most affected group (41.6%). Infections peaked during winter (40.7%) and were most frequent on lower limbs (43.35%). Novelty: This research represents one of the few longitudinal studies in Iraq detailing the spatial, temporal, and anatomical distribution of CL at the governorate level. Implications: The findings provide critical insights for targeted public health interventions and underscore the need for improved awareness, especially in rural areas, to control disease spread and reduce long-term health impacts.
Highlight :
-
Infection rates were higher among males (53.16%) and in rural areas (52.53%).
-
Children aged 5–15 years had the highest infection rate (41.6%) over the 4-year period.
-
Winter season showed the highest number of cases (40.7%), indicating a seasonal pattern of transmission.
Keywords : Cutaneous Leishmaniasis, Dhi-Qar Governorate, Epidemiology, Seasonal Variation, Public Health
References
[1] N. Abazid, C. Jones, and C. R. Davies, “Knowledge, attitudes and practices about leishmaniasis among cutaneous leishmaniasis patients in Aleppo, Syrian Arab Republic,” East. Mediterr. Health J., vol. 18, no. 1, pp. 7–14, 2012.
[2] A. Akram, H. A. A. Khan, A. Qadir, and A. M. Sabir, “A cross-sectional survey of knowledge, attitude and practices related to cutaneous leishmaniasis and sand flies in Punjab, Pakistan,” PLoS One, vol. 10, no. 6, p. e0130929, 2015.
[3] S. A. Anbareen, “Community involvement in controlling cutaneous leishmaniasis in Ikrampur village of District Mardan through dissemination of information among schoolchildren,” J. Appl. Environ. Biol. Sci., vol. 4, no. 8S, pp. 368–370, 2014.
[4] N. Aronson et al., “Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene,” Am. J. Trop. Med. Hyg., vol. 96, no. 1, pp. 24–45, 2017.
[5] M. E. Bracamonte et al., “High performance of an enzyme linked immunosorbent assay for American tegumentary leishmaniasis diagnosis with Leishmania (Viannia) braziliensis amastigotes membrane crude antigens,” PLoS One, vol. 15, no. 5, p. e0232829, 2020.
[6] A. Carvalho et al., “An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans,” Cell Immunol., vol. 318, pp. 42–48, 2017.
[7] R. C. F. De Brito et al., “Recent advances and new strategies in leishmaniasis diagnosis,” Appl. Microbiol. Biotechnol., vol. 104, no. 19, pp. 8105–8116, 2020.
[8] Ö. Ergönül et al., “Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees,” Clin. Microbiol. Infect., vol. 26, no. 3, pp. 307–312, 2020.
[9] M. L. Freire, F. D. Rêgo, G. Cota, M. A. Pascoal-Xavier, and E. Oliveira, “Potential antigenic targets used in immunological tests for diagnosis of tegumentary leishmaniasis: a systematic review,” PLoS One, vol. 16, no. 5, p. e0251956, 2021.
[10] S. H. Hejazi et al., “Evaluation of knowledge, attitude and performance of the mothers of children affected by cutaneous leishmaniasis,” Infect. Dis. Res. Treat., vol. 3, pp. 1–6, 2013.
[11] J. Heras-Mosteiro et al., “Interventions for Old World cutaneous leishmaniasis,” Cochrane Database Syst. Rev., vol. 2017, no. 11, p. CD005067, 2017.
[12] K. Khan, S. Wahid, N. H. Khan, and N. Ali, “Potential resting and breeding sites of sand flies (Diptera: Psychodidae) and their habitat characteristics in leishmaniasis foci of Dir Districts, Khyber Pakhtunkhwa, Pakistan,” J. Med. Entomol., vol. 54, no. 5, pp. 1390–1396, 2017.
[13] A. L. Martins, J. A. Barreto, J. R. Lauris, and A. C. Martins, “American tegumentary leishmaniasis: correlations among immunological, histopathological and clinical parameters,” An. Bras. Dermatol., vol. 89, no. 1, pp. 52–58, 2014.
[14] O. C. Moreira, Z. E. Yadon, and E. Cupolillo, “The applicability of real-time PCR in the diagnostic of cutaneous leishmaniasis and parasite quantification for clinical management: current status and perspectives,” Acta Trop., vol. 184, pp. 29–37, 2018.
[15] T. Rakhshani, M. Kashfi, M. R. Ebrahimi, S. Taravatmanesh, and M. Rasheki, “Knowledge, attitude and practice of the households about prevention of cutaneous leishmaniasis, Iran, Shiraz at 2016,” J. Hum. Environ. Health Promot., vol. 2, no. 3, pp. 186–192, 2017.
[16] L. Savioli and R. Velayudhan, “Small bite, big threat: World Health Day 2014,” East. Mediterr. Health J., vol. 20, no. 4, pp. 217–218, 2014.
[17] A. Q. Sousa et al., “Press imprint smear: a rapid, simple, and cheap method for the diagnosis of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis,” Am. J. Trop. Med. Hyg., vol. 91, no. 5, pp. 905–907, 2014.
[18] T. Sunyoto et al., “Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-Saharan Africa—a systematic review,” PLoS Negl. Trop. Dis., vol. 12, no. 10, p. e0006914, 2018.
[19] M. Solomon et al., “Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate,” J. Eur. Acad. Dermatol. Venereol., vol. 23, no. 10, pp. 1189–1192, 2009.
[20] S. van Henten et al., “Evaluation of the CL Detect Rapid Test in Ethiopian patients suspected for cutaneous leishmaniasis,” PLoS Negl. Trop. Dis., vol. 16, no. 1, p. e0010143, 2022.
[21] M. M. T. Vink et al., “Evaluation of point-of-care tests for cutaneous leishmaniasis diagnosis in Kabul, Afghanistan,” EBioMedicine, vol. 37, pp. 453–460, 2018.
[22] A. D. S. Zanetti et al., “Diagnostic accuracy of enzyme-linked immunosorbent assays to detect anti-Leishmania antibodies in patients with American tegumentary leishmaniasis: a systematic review,” Rev. Inst. Med. Trop. Sao Paulo, vol. 61, p. e42, 2019.
[23] T. Sunyoto, K. Verdonck, S. El Safi, J. Potet, A. Picado, and M. Boelaert, "Uncharted Territory of the Epidemiological Burden of Cutaneous Leishmaniasis in Sub-Saharan Africa—A Systematic Review," PLoS Neglected Tropical Diseases, vol. 12, no. 10, p. e0006914, 2018, doi: 10.1371/journal.pntd.0006914. (Duplicate of [18], retained to maintain original reference count.)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Athraa Shakir Dakhil
This work is licensed under a Creative Commons Attribution 4.0 International License.
